Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Liyue Hou
Observed name:
Hou, Liyue
Institution:
First Affiliated Hospital of Wenzhou Medical University
Observed institution:
First Affiliated Hospital of Wenzhou Medical University
ORCID:
0009-0001-0479-8000
Observed ORCID:
0009-0001-0479-8000
OpenAlex ID:
A5087135923
Light‐Responsive Biodegradable Nanorattles for Cancer Theranostics
2017
·
Chunxiao Li
, Yifan Zhang
, et al.
·
Advanced Materials
·
159
Gold-Nanobipyramid-Based Nanotheranostics for Dual-Modality Imaging-Guided Phototherapy
2020
·
Chunxiao Li
, Enci Mei
, et al.
·
ACS Applied Materials & Interfaces
·
47
MiR-217 is down-regulated in psoriasis and promotes keratinocyte differentiation via targeting GRHL2
2016
·
Haigang Zhu
, Liyue Hou
, et al.
·
Biochemical and Biophysical Research Communications
·
40
Theranostics: Light‐Responsive Biodegradable Nanorattles for Cancer Theranostics (Adv. Mater. 8/2018)
2018
·
Chunxiao Li
, Yifan Zhang
, et al.
·
Advanced Materials
·
18
PDF
Comparison of clinical and dermoscopic features between extramammary Paget’s disease and chronic eczema
2026
·
Lingjian Wu
, Liyue Hou
, et al.
·
Frontiers in Medicine
·
2
PDF
Real-World Chinese Study of the Effectiveness and Safety of Switching From Dupilumab to Stapokibart in Patients With Moderate-to-Severe Atopic Dermatitis
2026
·
Liyue Hou
, Lubing Li
, et al.
·
Dermatitis
·
2
Letter to “Increasing age at diagnosis raises malignancy risk and aminosalicylate intolerance influences therapeutic strategies in ulcerative colitis”
2026
·
Buyuan Dong
, Liyue Hou
·
Journal of Gastroenterology
·
1
PDF
Accuracy and validation of MISSLE model for SLN metastasis in melanoma
2025
·
Buyuan Dong
, Liyue Hou
·
Journal of the European Academy of Dermatology and Venereology
·
1
Cholesterol‐Lowering Diet and Female Hormone‐Related Cancer Risk
2025
·
Liyue Hou
, Buyuan Dong
·
BJOG An International Journal of Obstetrics & Gynaecology
·
1
Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial
2026
·
Liu, Jingjing
, Shao, Junyi
, et al.
·
Figshare
Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial
2026
·
Jingjing Liu
, Junyi Shao
, et al.
·
Journal of Dermatological Treatment
PDF
Real-world Efficacy and Safety of Stapokibart in Children and Adolescents with Moderate-to-severe Atopic Dermatitis: A Retrospective Study
2026
·
Lubing Li
, Yuqi Chen
, et al.
·
Acta Dermato Venereologica
Gold-Nanobipyramid-BasedNanotheranostics for Dual-ModalityImaging-Guided Phototherapy
2020
·
Chunxiao Li
, Enci Mei
, et al.
·
Figshare
Show more works
View as search
Works count:
13
Citation count:
271
H-index:
4
I10-index:
4
Year
Topic
Type